Evidence map›Paper›PMID 32076558›Full record

ArticleOpen heart2020

Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV.

Indulis Kumsars, Niels Ramsing Holm, Matti Niemelä, Andrejs Erglis, Kari Kervinen, Evald Høj Christiansen, Michael Maeng, Andis Dombrovskis, Vytautas Abraitis, Aleksandras Kibarskis and 22 more

Registry-linked trialAbstract readComparative StudyEquivalence TrialMulticenter Study
In one paragraph

Article in Open heart, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01496638 (How Should Coronary Artery Stenoses With Significant Side Branch be Stented? A Strategy of Stenting Both Main Vessel and Side Branch Compared to a Strategy of Stenting the Main Vessel and Only Stenting the Side Branch if Necessary.), which is not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01496638 naactive not recruitingnot on this map

How Should Coronary Artery Stenoses With Significant Side Branch be Stented? A Strategy of Stenting Both Main Vessel and Side Branch Compared to a Strategy of Stenting the Main Vessel and Only Stenting the Side Branch if Necessary.

TypeinterventionalSponsorEvald Hoej ChristiansenRan2008 to 2026Enrolled450ConditionsCoronary Artery DiseaseArmsImplantation of coronary stent in bifurcation lesion
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Coronary Bifurcation PCI-Part II: Advanced Considerations.Journal of cardiovascular development and disease · 2025
    Review
  7. Coronary Bifurcation PCI-Part I: Fundamentals.Journal of cardiovascular development and disease · 2025
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Percutaneous coronary intervention of bifurcation lesions.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Indulis Kumsars *Department of Cardiology, Latvia Center of Cardiology, Paul Stradins Clinical University Hospital, Riga, Latvia.
Niels Ramsing Holm *Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-2316-3107
Matti NiemeläDepartment of Cardiology, Oulu University Hospital, Oulu, Finland.
Andrejs ErglisResearch Institute of Cardiology and Regenerative Medicine, Latvia Centre of Cardiology, Riga, Latvia.
Kari KervinenDepartment of Cardiology, Oulu University Hospital, Oulu, Finland.
Evald Høj ChristiansenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Michael MaengDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Andis DombrovskisDepartment of Cardiology, Latvia Center of Cardiology, Paul Stradins Clinical University Hospital, Riga, Latvia.
Vytautas AbraitisDepartment of Cardiology, Vilnius University Hospital, Vilnius, Lithuania.
Aleksandras KibarskisDepartment of Cardiology, Vilnius University Hospital, Vilnius, Lithuania.
Thor TrovikDepartment of Cardiology, University of North Norway, Tromsoe, Norway.
Gustavs LatkovskisResearch Institute of Cardiology and Regenerative Medicine, Latvia Centre of Cardiology, Riga, Latvia.
Dace SondoreDepartment of Cardiology, Latvia Center of Cardiology, Paul Stradins Clinical University Hospital, Riga, Latvia.
Inga NarbuteResearch Institute of Cardiology and Regenerative Medicine, Latvia Centre of Cardiology, Riga, Latvia.
Christian Juhl TerkelsenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Markku EskolaDepartment of Cardiology, Heart Center, Tampere University Hospital, Tampere, Finland.
Hannu RomppanenDepartment of cardiology, Heart Center, Kuopio University Hospital, Kuopio, Finland.
Mika LaineDepartment of Cardiology, Helsinki University Central Hospital, Helsinki, Finland.
Lisette Okkels JensenDepartment of Cardiology, Odense University Hospital, Odense, Denmark.
Mikko PietilaDepartment of Cardiology, Turku University Hospital, Turku, Finland.
Pål GunnesHeart Center, Sørlandet Hospital, Arendal, Norway.
Lasse HebsgaardDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Ole FrobertÖrebro University, Faculty of Health, Department of Cardiology, Örebro, Sweden.
Fredrik CalaisÖrebro University, Faculty of Health, Department of Cardiology, Örebro, Sweden.
Juha HartikainenDepartment of cardiology, Heart Center, Kuopio University Hospital, Kuopio, Finland.
Jens AarøeDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Jan RavkildeDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Thomas EngstrømDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Terje K SteigenDepartment of Cardiology, University Hospital of North Norway, Tromsoe and Cardiovascular Diseases Research Group, UiT The Arctic University of Norway, Tromsø, Norway.
Leif ThuesenDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Jens F LassenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Nordic Baltic bifurcation study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is still uncertain whether coronary bifurcations with lesions involving a large side branch (SB) should be treated by stenting the main vessel and provisional stenting of the SB (simple) or by routine two-stent techniques (complex). We aimed to compare clinical outcome after treatment of lesions in large bifurcations by simple or complex stent implantation. Methods: The study was a randomised, superiority trial. Enrolment required a SB≥2.75 mm, ≥50% diameter stenosis in both vessels, and allowed SB lesion length up to 15 mm. The primary endpoint was a composite of cardiac death, non-procedural myocardial infarction and target lesion revascularisation at 6 months. Two-year clinical follow-up was included in this primary reporting due to lower than expected event rates. Results: A total of 450 patients were assigned to simple stenting (n=221) or complex stenting (n=229) in 14 Nordic and Baltic centres. Two-year follow-up was available in 218 (98.6%) and 228 (99.5%) patients, respectively. The primary endpoint of major adverse cardiac events (MACE) at 6 months was 5.5% vs 2.2% (risk differences 3.2%, 95% CI -0.2 to 6.8, p=0.07) and at 2 years 12.9% vs 8.4% (HR 0.63, 95% CI 0.35 to 1.13, p=0.12) after simple versus complex treatment. In the subgroup treated by newer generation drug-eluting stents, MACE was 12.0% vs 5.6% (HR 0.45, 95% CI 0.17 to 1.17, p=0.10) after simple versus complex treatment. Conclusion: In the treatment of bifurcation lesions involving a large SB with ostial stenosis, routine two-stent techniques did not improve outcome significantly compared with treatment by the simpler main vessel stenting technique after 2 years. Trial registration number: NCT01496638.

Indexed as

Drug-Eluting StentsAgedAngioplasty, Balloon, CoronaryCoronary Artery DiseaseCoronary StenosisFemaleHumansLatviaLithuaniaMaleMiddle AgedMyocardial InfarctionProspective StudiesRisk FactorsScandinavian and Nordic CountriesTime Factorscomplex coronary lesionscoronary bifurcationsdrug eluting stents

Identifiers

PMID32076558
PMCPMC6999681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.